PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Internal Medicine, Radboudumc Center for Infectious Diseases (RCI), Radboudumc, Nijmegen, Netherlands.\', \'Department for Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.\', \'Department of Pharmacy, Radboudumc Center for Infectious Diseases (RCI), Radboudumc, Nijmegen, Netherlands.\', \'Intensive Care, Radboudumc Center for Infectious Diseases (RCI), Radboudumc, Nijmegen, Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.57555e57555
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 32338605
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all